FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384071816> ?p ?o ?g. }

• W4384071816 endingPage "4059" @default.
• W4384071816 startingPage "4042" @default.
• W4384071816 abstract "Pharmacological asthma management focuses on the use of inhaled corticosteroid (ICS)-containing therapies, which reduce airway inflammation and provide bronchoprotection, improving symptom control and reducing exacerbation risk. ICS underuse due to poor adherence is common, leading to poor clinical outcomes including increased risk of mortality. This article reviews efficacy versus systemic activity profiles for various adherence patterns and dosing regimens of fluticasone furoate (FF)-containing and budesonide (BUD)-containing asthma therapies in clinical trials and real-world studies. We performed a structured literature review (1 January 2000–3 March 2022) and mathematical modelling analysis of FF-containing and BUD-containing regular daily dosing in patients with mild-to-severe asthma, as-needed BUD/formoterol (FOR) in mild asthma, and BUD/FOR maintenance and reliever therapy (MART) dosing in moderate-to-severe asthma, to assess efficacy (bronchoprotection) and systemic activity (cortisol suppression) profiles of dosing patterns of ICS use in multiple adherence scenarios. A total of 22 manuscripts were included in full-text review and 18 in the model simulations. Focusing on FF-containing or BUD-containing treatments at comparable adherence rates, regular daily FF or FF/vilanterol (VI) dosing provided more prolonged bronchoprotection and fewer systemic effects than daily BUD, daily BUD/FOR, or BUD/FOR MART dosing, especially in low adherence scenarios. In model simulations and the real-world setting, FF/VI generally provided longer bronchoprotection, lower systemic activity, and greater clinical benefits over BUD/FOR as well as consistently higher adherence. In this literature review and modelling analysis, FF/VI was found to show clinical advantages on asthma control over BUD/FOR. These findings have implications for helping clinicians select the most suitable inhaled therapy for their patients with asthma." @default.
• W4384071816 created "2023-07-13" @default.
• W4384071816 creator A5030652345 @default.
• W4384071816 creator A5057258487 @default.
• W4384071816 creator A5059497342 @default.
• W4384071816 creator A5062449253 @default.
• W4384071816 creator A5068917661 @default.
• W4384071816 creator A5087553850 @default.
• W4384071816 creator A5089497961 @default.
• W4384071816 date "2023-07-12" @default.
• W4384071816 modified "2023-10-08" @default.
• W4384071816 title "Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management" @default.
• W4384071816 cites W1963853409 @default.
• W4384071816 cites W1991968623 @default.
• W4384071816 cites W2000363971 @default.
• W4384071816 cites W2039130845 @default.
• W4384071816 cites W2039206076 @default.
• W4384071816 cites W2052009785 @default.
• W4384071816 cites W2057621677 @default.
• W4384071816 cites W2062765710 @default.
• W4384071816 cites W2074567872 @default.
• W4384071816 cites W2076199084 @default.
• W4384071816 cites W2077456532 @default.
• W4384071816 cites W2084593964 @default.
• W4384071816 cites W2085902327 @default.
• W4384071816 cites W2090165561 @default.
• W4384071816 cites W2094500194 @default.
• W4384071816 cites W2094640172 @default.
• W4384071816 cites W2099379311 @default.
• W4384071816 cites W2101045381 @default.
• W4384071816 cites W2108545239 @default.
• W4384071816 cites W2111971457 @default.
• W4384071816 cites W2122276030 @default.
• W4384071816 cites W2139148381 @default.
• W4384071816 cites W2141501933 @default.
• W4384071816 cites W2143096094 @default.
• W4384071816 cites W2147267738 @default.
• W4384071816 cites W2157910210 @default.
• W4384071816 cites W2161775889 @default.
• W4384071816 cites W2162313549 @default.
• W4384071816 cites W2162552418 @default.
• W4384071816 cites W2165209634 @default.
• W4384071816 cites W2171365228 @default.
• W4384071816 cites W2261570023 @default.
• W4384071816 cites W2272818989 @default.
• W4384071816 cites W2340696410 @default.
• W4384071816 cites W2552094662 @default.
• W4384071816 cites W2753577203 @default.
• W4384071816 cites W2804556773 @default.
• W4384071816 cites W2804974483 @default.
• W4384071816 cites W2806455738 @default.
• W4384071816 cites W2892149652 @default.
• W4384071816 cites W2942601784 @default.
• W4384071816 cites W2946771756 @default.
• W4384071816 cites W2969375889 @default.
• W4384071816 cites W2974795038 @default.
• W4384071816 cites W2980885341 @default.
• W4384071816 cites W3023860784 @default.
• W4384071816 cites W3025904018 @default.
• W4384071816 cites W3029301343 @default.
• W4384071816 cites W3171646325 @default.
• W4384071816 cites W3175117496 @default.
• W4384071816 cites W3191744610 @default.
• W4384071816 cites W4200396556 @default.
• W4384071816 cites W4212787287 @default.
• W4384071816 cites W4220936373 @default.
• W4384071816 cites W4224299946 @default.
• W4384071816 cites W4290058845 @default.
• W4384071816 cites W4293433640 @default.
• W4384071816 doi "https://doi.org/10.1007/s12325-023-02585-z" @default.
• W4384071816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37438554" @default.
• W4384071816 hasPublicationYear "2023" @default.
• W4384071816 type Work @default.
• W4384071816 citedByCount "0" @default.
• W4384071816 crossrefType "journal-article" @default.
• W4384071816 hasAuthorship W4384071816A5030652345 @default.
• W4384071816 hasAuthorship W4384071816A5057258487 @default.
• W4384071816 hasAuthorship W4384071816A5059497342 @default.
• W4384071816 hasAuthorship W4384071816A5062449253 @default.
• W4384071816 hasAuthorship W4384071816A5068917661 @default.
• W4384071816 hasAuthorship W4384071816A5087553850 @default.
• W4384071816 hasAuthorship W4384071816A5089497961 @default.
• W4384071816 hasBestOaLocation W43840718161 @default.
• W4384071816 hasConcept C126322002 @default.
• W4384071816 hasConcept C2776042228 @default.
• W4384071816 hasConcept C2776136866 @default.
• W4384071816 hasConcept C2776804153 @default.
• W4384071816 hasConcept C2777014857 @default.
• W4384071816 hasConcept C2777288759 @default.
• W4384071816 hasConcept C2777450039 @default.
• W4384071816 hasConcept C2779028295 @default.
• W4384071816 hasConcept C2779871671 @default.
• W4384071816 hasConcept C2781212218 @default.
• W4384071816 hasConcept C2781348165 @default.
• W4384071816 hasConcept C71924100 @default.
• W4384071816 hasConceptScore W4384071816C126322002 @default.
• W4384071816 hasConceptScore W4384071816C2776042228 @default.
• W4384071816 hasConceptScore W4384071816C2776136866 @default.

• next